PDT Partners’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-12,104
Closed -$1.89M 941
2020
Q4
$1.89M Sell
12,104
-43,647
-78% -$5.61M 0.13% 252
2020
Q3
$6.38M Sell
55,751
-11,889
-18% -$1.28M 0.42% 87
2020
Q2
$7.59M Sell
67,640
-41,519
-38% -$4.41M 0.52% 62
2020
Q1
$9.8M Buy
109,159
+25,028
+30% +$2.46M 0.78% 11
2019
Q4
$9.1M Buy
+84,131
New +$9M 0.56% 62
2019
Q3
Sell
-79,500
Closed -$10.4M 499
2019
Q2
$10.4M Hold
79,500
0.62% 36
2019
Q1
$10.7M Sell
79,500
-37
-0% -$4.6K 0.61% 37
2018
Q4
$7.74M Buy
79,537
+25
+0% +$2.96K 0.43% 87
2018
Q3
$11.1M Buy
+79,512
New +$9.97M 0.46% 60
2015
Q4
Sell
-60,440
Closed -$9.45M 1076
2015
Q3
$9.45M Buy
+60,440
New +$11M 0.21% 127
2015
Q2
Sell
-60,173
Closed -$10.4M 1742
2015
Q1
$10.4M Buy
60,173
+55,473
+1,180% +$10M 0.26% 86
2014
Q4
$870K Sell
4,700
-1,000
-18% -$185K 0.08% 358
2014
Q3
$945K Sell
5,700
-72,131
-93% -$11.8M 0.02% 674
2014
Q2
$12.2M Sell
77,831
-82,559
-51% -$13M 0.32% 57
2014
Q1
$24.4M Buy
160,390
+158,271
+7,469% +$25.2M 0.59% 22
2013
Q4
$282K Sell
2,119
-20,316
-91% -$2.44M 0.03% 537
2013
Q3
$2.61M Sell
22,435
-90,724
-80% -$9.95M 0.07% 385
2013
Q2
$10.4M Buy
+113,159
New +$10.9M 0.26% 78

Other funds holding ALXN